Susquehanna International Group, LLP Cybin Inc. Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.26 - $0.64 $2,782 - $6,848	10,701 New	10,701 $3,000
Q1 2022 May 16, 2022	SELL	$0.74 - $1.22 $36,213 - $59,703	-48,937 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.13 - $2.31 $42,586 - $87,056	37,687 Added 335.0%	48,937 $59,000
Q3 2021 Nov 15, 2021	BUY	$1.83 - $3.18 $20,587 - $35,775	11,250 New	11,250 $25,000

66.1K

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $1.58B
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.